TY - JOUR AR - JICOA-2020-4-104 TI - Interaction between Statins and Omega 3 Poly-unsaturated Fatty Acids in Cardiovascular Disease: Synergistic or Not? AU - Forel , Céline AU - Messager , Laureen AU - Sierra , Camille AU - Contreras , Ivette AU - Légère , Simon AU - Pessiot-Royer , Solène AU - Jean-Yves LE, GUENNEC AU - Demion , Marie JO - Journal of Integrative Cardiology Open Access PY - 2020 DA - Fri 10, Jul 2020 SN - 2674-2489 DO - http://dx.doi.org/10.31487/j.JICOA.2020.04.04 UR - https://www.sciencerepository.org/interaction-between-statins-and-omega-3-poly-unsaturated-fatty-acids_JICOA-2020-4-104 KW - Omega-3, PUFA, DHA, EPA, statin, cardiovascular disease, atherosclerosis, dyslipidemia, hypertriglyceridemia, coronary heart disease, n-3/n-6 ratio AB - Up to the middle of the 2000’s, omega 3 polyunsaturated fatty acids were considered has having cardioprotective properties. Patients having a myocardial infarction were supplemented with these fatty acids in secondary prevention of myocardial infarction. Since then, many randomized clinical trials failed to observe the cardioprotective effects previously described. The main hypothesis to explain such change is the systematic prescription of statins to patients following a myocardial infarction, statins interfering with the homeostasis of omega 3 fatty acids. This review discusses the effects of different forms of omega-3 in association with statins on cardiovascular disease and emphasize on the interaction between statins and omega 3 fatty acids leading to the possible need to use higher dose of fatty acids to get a synergistic effect.